BeyondSpring BYSI
NASDAQ BYSI
$0.72 +0.00 (+0.00%)
At close: Aug 21, 2026 · 4:00 PM EDT

BeyondSpring (BYSI) Cash & Equivalents (2015 - 2026)

BeyondSpring (BYSI) posted Cash & Equivalents of $4.0 million for Q1 2026, down 48.16% sequentially from $7.8 million in Q4 2025, and down 38.16% YoY from $6.5 million in Q1 2025.

BeyondSpring (BYSI) Cash & Equivalents (2015 - 2026) Analysis & Trends

BeyondSpring has reported Cash & Equivalents for 12 years, with the latest figure at $4.0 million in Q1 2026.

  • Quarterly Cash & Equivalents fell 38.16% year-over-year to $4.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.0 million (down 38.16% YoY) and the FY2025 annual result came in at $7.8 million, up 166.46% from the prior year.
  • Cash & Equivalents slipped to $4.0 million in Q1 2026 per BYSI's latest filing, from $7.8 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $34.4 million in Q4 2022 and troughed at $2.9 million in Q4 2024.
  • A 5-year average of $12.3 million and a median of $8.4 million in 2024 frame the typical range for Cash & Equivalents.
  • The sharpest annual moves came in 2023 and 2025: Cash & Equivalents tumbled 84.31% in 2023, then surged 166.46% in 2025.
  • Over 5 years, Cash & Equivalents stood at $34.4 million in 2022, then sank by 84.31% to $5.4 million in 2023, then slumped by 45.85% to $2.9 million in 2024, then soared by 166.46% to $7.8 million in 2025, then tumbled by 48.16% to $4.0 million in 2026.
  • According to Business Quant data, Cash & Equivalents over the past three periods registered $4.0 million, $7.8 million, and $12.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 6.14 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 2.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 3.58 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 1.72 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 5.10 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 1.71 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 8.93 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 544.80 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 811.99 Mn
10 BeyondSpring 29.85 Mn 29.85 Mn - 6.53 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 6.53 Mn
Mar 31, 2026 4.04 Mn
Dec 31, 2025 7.79 Mn
Sep 30, 2025 12.48 Mn
Jun 30, 2025 9.54 Mn
Mar 31, 2025 6.53 Mn
Dec 31, 2024 2.92 Mn
Jun 30, 2024 8.40 Mn
Dec 31, 2023 5.40 Mn
Jun 30, 2023 13.49 Mn
Dec 31, 2022 34.40 Mn
Jun 30, 2022 30.74 Mn
Dec 31, 2021 41.63 Mn
Sep 30, 2021 91.60 Mn
Jun 30, 2021 51.31 Mn
Mar 31, 2021 90.57 Mn
Dec 31, 2020 109.54 Mn
Sep 30, 2020 30.87 Mn
Jun 30, 2020 38.08 Mn
Mar 31, 2020 24.92 Mn